First Time Loading...
A

Aelis Farma SA
PAR:AELIS

Watchlist Manager
Aelis Farma SA
PAR:AELIS
Watchlist
Price: 13.1 EUR
Updated: May 15, 2024
Section:
 

Wall Street
Price Targets

AELIS Price Targets Summary
Aelis Farma SA

Wall Street analysts forecast AELIS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AELIS is 21.08 EUR with a low forecast of 19.19 EUR and a high forecast of 24.15 EUR.

AELIS Lowest Forecast
Wall Street Target
19.19 EUR
46% Upside
AELIS Average Forecast
Wall Street Target
21.08 EUR
61% Upside
AELIS Highest Forecast
Wall Street Target
24.15 EUR
84% Upside
Lowest
Price Target
19.19 EUR
46% Upside
Average
Price Target
21.08 EUR
61% Upside
Highest
Price Target
24.15 EUR
84% Upside
Aelis Farma SA Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
8% Downside
MGNX
MacroGenics Inc
468% Upside
SPRO
Spero Therapeutics Inc
378% Upside
INCY
Incyte Corp
29% Upside
PTCT
PTC Therapeutics Inc
8% Downside
MGNX
MacroGenics Inc
468% Upside
SPRO
Spero Therapeutics Inc
378% Upside
INCY
Incyte Corp
29% Upside
300406
Beijing Strong Biotechnologies Inc
25% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
43% Upside
PRQR
ProQR Therapeutics NV
118% Upside
W
300142
Walvax Biotechnology Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Aelis Farma SA

The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is -19%.

N/A
Past Growth
-19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Aelis Farma SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Aelis Farma SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
AELIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AELIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AELIS stock valuation using valuation multiples.
Wall Street Estimates
AELIS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AELIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AELIS's stock price target?
Price Target
21.08 EUR

According to Wall Street analysts, the average 1-year price target for AELIS is 21.08 EUR with a low forecast of 19.19 EUR and a high forecast of 24.15 EUR.

What is Aelis Farma SA's Revenue forecast?
Projected CAGR
-19%

The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is -19%.

ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.